Recent Developments in Glycine Transporter-1 Inhibitors

被引:9
|
作者
Cioffi, Christopher L. [1 ]
Liu, Shuang [1 ]
Wolf, Mark A. [1 ]
机构
[1] AMRI, Albany, NY 12203 USA
来源
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45 | 2010年 / 45卷
关键词
SELECTIVE GLYT1 INHIBITORS; PHENCYCLIDINE-INDUCED HYPERACTIVITY; HALOPERIDOL-INDUCED CATALEPSY; RECEPTOR-MEDIATED RESPONSES; IN-VIVO; SUBSTITUTED SPIROPIPERIDINES; DISCOVERY; SCHIZOPHRENIA; TYPE-1; POTENT;
D O I
10.1016/S0065-7743(10)45002-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:19 / 35
页数:17
相关论文
共 50 条
  • [21] Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1)
    Manahan-Vaughan, Denise
    Wildfoerster, Verena
    Thomsen, Christian
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 28 (07) : 1342 - 1350
  • [23] Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats
    Kawaura, Kazuaki
    Koike, Hiroyuki
    Kinoshita, Kohnosuke
    Kambe, Daiji
    Kaku, Ayaka
    Karasawa, Jun-ichi
    Chaki, Shigeyuki
    Hikichi, Hirohiko
    BEHAVIOURAL BRAIN RESEARCH, 2015, 278 : 186 - 192
  • [24] The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter
    Lowe, John A., III
    Hou, Xinjun
    Schmidt, Christopher
    Tingley, F. David, III
    McHardy, Stan
    Kalman, Monica
    DeNinno, Shari
    Sanner, Mark
    Ward, Karen
    Lebel, Lorraine
    Tunucci, Don
    Valentine, James
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (11) : 2974 - 2976
  • [25] Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia
    Boulay, Denis
    Pichat, Philippe
    Dargazanli, Gihad
    Estenne-Bouhtou, Genevieve
    Terranova, Jean Paul
    Rogacki, Nancy
    Stemmelin, Jeanne
    Coste, Annick
    Lanneau, Christophe
    Desvignes, Christophe
    Cohen, Caroline
    Alonso, Richard
    Vige, Xavier
    Biton, Bruno
    Steinberg, Regis
    Sevrin, Mireille
    Oury-Donat, Florence
    George, Pascal
    Bergis, Olivier
    Griebel, Guy
    Avenet, Patrick
    Scatton, Bernard
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 91 (01) : 47 - 58
  • [26] The phosphodiesterase-4 and glycine transporter-1 inhibitors enhance in vivo hippocampal theta network connectivity and synaptic plasticity, whereas D-serine does not
    Ahnaou, A.
    Broadbelt, T.
    Biermans, R.
    Huysmans, H.
    Manyakov, N. V.
    Drinkenburg, W. H. I. M.
    TRANSLATIONAL PSYCHIATRY, 2020, 10 (01)
  • [27] A Highly Selective Inhibitor of Glycine Transporter-1 Elevates the Threshold for Maximal Electroshock-Induced Tonic Seizure in Mice
    Zhao, Jianghao
    Tao, Hua
    Xian, Wenchuan
    Cai, Yujie
    Cheng, Wanwen
    Yin, Mingkang
    Lang, Guocong
    Li, Keshen
    Cui, Lili
    Zhao, Bin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (02) : 174 - 180
  • [28] Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects
    D'Souza, Deepak Cyril
    Carson, Richard E.
    Driesen, Naomi
    Johannesen, Jason
    Ranganathan, Mohini
    Krystal, John H.
    BIOLOGICAL PSYCHIATRY, 2018, 84 (06) : 413 - 421
  • [29] Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016?2019)
    Dong, Yue
    Zhao, Tong
    Ai, Wei
    Zalloum, Waleed A.
    Kang, Dongwei
    Wu, Ting
    Liu, Xinyong
    Zhan, Peng
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (11) : 871 - 879
  • [30] An octahydro-cyclopenta[c]pyrrole series of inhibitors of the type 1 glycine transporter
    Lowe, John A., III
    DeNinno, Shari L.
    Drozda, Susan E.
    Schmidt, Christopher J.
    Ward, Karen M.
    Tingley, F. David, III
    Sanner, Mark
    Tunucci, Don
    Valentine, James
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 907 - 911